DiogenX raised €28M in a Series A round in May 2023. The company is based in Marseille, France. Investors in the round: AdBio partners, Boehringer Ingelheim Venture Fund, Eli lilly and company and 3 others. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €28M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
